Nasus Pharma
Nasus Pharma
Explore linked clinical trials.3 results ยท Page 1 of 1
Clinical trials
Swipe the table sideways for more columns.
| Trial | Conditions | Status | Phase | Updated | More info | NCT ID |
|---|---|---|---|---|---|---|
| A Study to Compare the Bioavailability of Ondansetron Following Nasal (NS003) and IV Administration in Healthy Adults | Nausea, Pathologic Processes, Pathological Conditions, Signs and Symptoms, Postoperative Complications, Postoperative Nausea and Vomiting, Signs and Symptoms, Signs and Symptoms, Digestive, Vomiting | Recruiting | Phase 1 | 2026-10-09 | NCT07868861 | |
| Comparative PK/PD of FMXIN002 and EpiPen, in Healthy Adults With Allergic Rhinitis | Hypersensitivity, Immediate, allergic disease, anaphylaxis, immune system disorder | Enrolling by invitation | Phase 1 / Phase 2 | 2025-11-14 | NCT07228325 | |
| FMXIN002 in Patients at Risk of Anaphylaxis | Anaphylaxis Food | Enrolling by invitation | Phase 2 / Phase 3 | 2025-07-01 | NCT07045701 |